English | Español
English | Español

Community

+ Community
Carol Ostrow | Dec 27, 2017

South Dakota hospital CEO awarded rural leadership prize

+ Community
Carol Ostrow | Dec 27, 2017

Study: One-fourth of California youth report being viewed as gender nonconforming

+ Community
Kathy Adams | Dec 27, 2017

UCLA Health's fitness program improves youth fitness, research shows

+ Technology/Innovation
Carol Ostrow | Dec 27, 2017

UCLA researchers find pregnant women's high glucose levels affect fetal heart growth

+ Technology/Innovation
Carol Ostrow | Dec 27, 2017

Restrictions on Opdivo combination trials for multiple myeloma treatment lifted by FDA

+ Technology/Innovation
Carol Ostrow | Dec 27, 2017

Seattle Genetics, Bristol-Myers Squibb report Hodgkin treatment study interim results

+ Community
Kathy Adams | Dec 27, 2017

Santa's Elves program brings holiday cheer to Brenner Children's Hospital patients

+ Community
Carol Ostrow | Dec 27, 2017

Chemotherapy can cause UTIs in breast cancer patients, urologist says

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

  • « First
  • «
  • …
  • 354
  • 355
  • 356
  • 357
  • 358
  • 359
  • 360
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily